Toronto, Ontario / ACCESSWIRE / January 13, 2015 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (EIY2.F) (the "Company"), a developer of in vitro diagnostics and point-of-care technologies is pleased to announce that the Company will be presenting and exhibiting at the Cantech '15 Technology Conference on Thursday, January 15, 2015 in Toronto, Ontario Canada.
ChroMedX President and CEO, Dr. Wayne Maddever, will be conducting a feature presentation covering the Company's technologies and 2015 development program at 2:50pm on Thursday on the PI Financial Innovation Stage at the Metro Toronto Convention Centre.
The conference's exhibit hall opens at 10am and ChroMedX Corp. can be found at booth 206. The event is open to the public and the Company looks forward to discussion with all interested parties.
About Cantech '15
The Cantech Investment Conference brings together the top thought leaders, fastest growing companies and most influential investors in the country for a full day exposition at the Metro Toronto Convention Centre. This is the ultimate showcase for Canadian technology development and investor opportunities.
Metro Toronto Convention Centre
255 Front Street West
Toronto,
ON, M5V 2W6
Canada
About ChroMedX Corp.
ChroMedX Corp. is a medical technology company focused on the development of novel medical devices for in vitro diagnostics and point-of-care testing. The devices are protected by the Company's issued US and pending international patents, dealing with blood collection, analysis and plasma/serum processing.
Follow ChroMedX Corp.:
Website: www.ChroMedX.com
Facebook:
facebook.com/ChroMedXcorp
Twitter: www.twitter.com/ChroMedXcorp
Investor Enquiries:
W. Clark Kent
Corporate Development
647-519-2646
[email protected]
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Forward-looking Information Cautionary Statement
Except for statements of historic fact, this news release
contains certain "forward-looking information" within the meaning of applicable
securities law. Forward-looking information is frequently characterized by words
such as "plan", "expect", "project", "intend", "believe", "anticipate",
"estimate" and other similar words, or statements that certain events or
conditions "may" or "will" occur. Forward-looking statements are based on the
opinions and estimates at the date the statements are made, and are subject to a
variety of risks and uncertainties and other factors that could cause actual
events or results to differ materially from those anticipated in the
forward-looking statements including, but not limited to delays or uncertainties
with regulatory approvals, including that of the CSE. There are uncertainties
inherent in forward-looking information, including factors beyond the Company's
control. The Company undertakes no obligation to update forward-looking
information if circumstances or management's estimates or opinions should change
except as required by law. The reader is cautioned not to place undue reliance
on forward-looking statements. Additional information identifying risks and
uncertainties that could affect financial results is contained in the Company's
filings with Canadian securities regulators, which filings are available at
www.sedar.com
SOURCE: ChroMedX Corp.